Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Comment by Golddetectoron Aug 05, 2021 8:59pm
130 Views
Post# 33661709

RE:RE:Volume

RE:RE:Volume Agreed. The preliminary analysis of QIXLEEF trials will be great. We are already in aug so it won't be long before we see something. Actually non of the q3 & q4 catalysts took place yet. So the next few weeks will have some action. We all saw how sp can fly on trial start. Now we are talking results and din approval ard trial start. No concerns about results from my side. I reviewed multiple studies that showed cannabis use improve pain control over opioid not to mention the quick release of QIXLEEF. The only concern a take over below 1 billion which very possible imo with sp at these level. Tbp is most advanced in its trials do you think big pharma let that happen. I hope big pharma will leave us alone for the next few week. Once it hit 2 or 3 dollars they can do whatever. Jmo
<< Previous
Bullboard Posts
Next >>